CDMO Profile

BioInnovatse

BioInnovatse Contract Manufacturing & Development (CDMO) Profile

BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor, BioCapital, and beyond. Our teams advise and produce custom projects that further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA.

We specialize in molecular biology products and services to advance research in the early discovery phases of cell and gene therapy, immunotherapy, precision medicine, regenerative medicine, stem cell research, and vaccine development.

Researchers rely on our commitment to high-quality production with minimal turnaround time. We look forward to supporting researchers in their pursuit of making new breakthroughs in their respective fields.

CDMO Services:
Biologics; Cell & Gene Therapy Research & Development

Year Founded: 2009

Head Office: Rockville, United States

Number of Facilities: 1-2

Facility locations: North America

Website: Visit the BioInnovatse website

Linkedin: Connect on Linkedin

Current Capacity: Plasmid DNA and viral vector productions for early discovery applications and volumes ranging from cell cultures to rat models.

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

SURVEY

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.